Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT03547063
Other study ID # 18/0233
Secondary ID
Status Suspended
Phase
First received
Last updated
Start date December 18, 2018
Est. completion date December 2022

Study information

Verified date January 2021
Source University College, London
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to gain insight into brain structure and the neural networks that control taste and eating behaviour in patients with severe obesity undergoing a primary sleeve gastrectomy (SG) or a lifestyle intervention for weight loss compared with normal weight individuals, using functional magnetic resonance imaging (fMRI).


Description:

This is an observational study aiming to gain insight into brain structure and the neural networks that control taste and eating behaviour in patients with severe obesity undergoing a primary sleeve gastrectomy (SG) or a lifestyle intervention for weight loss compared with normal weight individuals using functional magnetic resonance imaging (fMRI). Drops of liquid foods and a control solution will be delivered to the participants' mouth during fMRI scanning. Body weight, gut hormones from serial blood samples, appetite scores and taste will be assessed at each study visit.


Recruitment information / eligibility

Status Suspended
Enrollment 75
Est. completion date December 2022
Est. primary completion date December 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Female and male adults aged 18-50 years. - Right-handed. - No MRI contra-indications. - Weight stable at time of recruitment, defined as less than 5% variation in body weight over the preceding 3 months. - Proficient in written and spoken English. - Able to comply with study protocol. - Willing and able to provide written informed consent. - Participants must be registered with a general practitioner (GP). - Willing for their treating consultant or their GP and the study team to be informed in the event of an incidental abnormal finding being detected by the investigations or assessments that form part of this study. - Able to lie flat for 1 hour. Group-specific inclusion criteria: - SG group: - BMI of 35-50 kg/m2 - Planned to undergo primary SG surgery and fulfilling eligibility criteria for bariatric surgery. - Lifestyle intervention group: - BMI of 35-50 kg/m2 - Willing to undergo a lifestyle intervention programme with a view to achieving approximately 10% weight loss. - Normal weight group: - BMI 18.5-24.9 kg/m2 Exclusion Criteria: - Body weight greater than 130kg (due to weight limit of MRI Scanner). - Contraindications specific to MRI scanning: metallic implants (cardiac pacemakers, aneurysm clips, permanent eye lining, cochlear implants or anyone who has been exposed to metallic flakes or splinters). - Type 1 and type 2 diabetes (in view of altered circulated gut hormone profiles and gustatory function). - Menopause (in view of findings that the menopause affects gustatory function). - Smoking (in view of the fact that smoking affects salivary gut hormones and gustatory function). - Vitamin B12 or zinc deficiency (in view of deficiencies affecting gustatory function). - Untreated severe depression. - Eating disorders including bulimia and self-induced vomiting. - Neurological or psychiatric conditions. - Acute illness or chronic conditions that may impact upon gustatory and olfactory function. - Acute illness or chronic conditions that may impact upon post-operative weight loss. - Known or suspected history of HIV, Hepatitis B or C or other blood-borne diseases (in view of safety regulations regarding exposure to blood products) - Pregnancy or lactation.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom University College London Hospital London

Sponsors (1)

Lead Sponsor Collaborator
University College, London

Country where clinical trial is conducted

United Kingdom, 

References & Publications (7)

Batterham RL, ffytche DH, Rosenthal JM, Zelaya FO, Barker GJ, Withers DJ, Williams SC. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature. 2007 Nov 1;450(7166):106-9. Epub 2007 Oct 14. — View Citation

Faulconbridge LF, Ruparel K, Loughead J, Allison KC, Hesson LA, Fabricatore AN, Rochette A, Ritter S, Hopson RD, Sarwer DB, Williams NN, Geliebter A, Gur RC, Wadden TA. Changes in neural responsivity to highly palatable foods following roux-en-Y gastric bypass, sleeve gastrectomy, or weight stability: An fMRI study. Obesity (Silver Spring). 2016 May;24(5):1054-60. doi: 10.1002/oby.21464. — View Citation

Goldstone AP, Miras AD, Scholtz S, Jackson S, Neff KJ, Pénicaud L, Geoghegan J, Chhina N, Durighel G, Bell JD, Meillon S, le Roux CW. Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity. J Clin Endocrinol Metab. 2016 Feb;101(2):599-609. doi: 10.1210/jc.2015-2665. Epub 2015 Nov 18. — View Citation

Karra E, O'Daly OG, Choudhury AI, Yousseif A, Millership S, Neary MT, Scott WR, Chandarana K, Manning S, Hess ME, Iwakura H, Akamizu T, Millet Q, Gelegen C, Drew ME, Rahman S, Emmanuel JJ, Williams SC, Rüther UU, Brüning JC, Withers DJ, Zelaya FO, Batterham RL. A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest. 2013 Aug;123(8):3539-51. doi: 10.1172/JCI44403. Epub 2013 Jul 15. — View Citation

Makaronidis JM, Neilson S, Cheung WH, Tymoszuk U, Pucci A, Finer N, Doyle J, Hashemi M, Elkalaawy M, Adamo M, Jenkinson A, Batterham RL. Reported appetite, taste and smell changes following Roux-en-Y gastric bypass and sleeve gastrectomy: Effect of gender, type 2 diabetes and relationship to post-operative weight loss. Appetite. 2016 Dec 1;107:93-105. doi: 10.1016/j.appet.2016.07.029. Epub 2016 Jul 22. — View Citation

Neseliler S, Han JE, Dagher A. The Use of Functional Magnetic Resonance Imaging in the Study of Appetite and Obesity. In: Harris RBS, editor. Appetite and Food Intake: Central Control. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2017. Chapter 6. — View Citation

Zhang Y, Ji G, Xu M, Cai W, Zhu Q, Qian L, Zhang YE, Yuan K, Liu J, Li Q, Cui G, Wang H, Zhao Q, Wu K, Fan D, Gold MS, Tian J, Tomasi D, Liu Y, Nie Y, Wang GJ. Recovery of brain structural abnormalities in morbidly obese patients after bariatric surgery. Int J Obes (Lond). 2016 Oct;40(10):1558-1565. doi: 10.1038/ijo.2016.98. Epub 2016 May 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary BOLD signal change after SG To determine the effect of SG, at 10% weight loss, upon whole-brain neural response to taste, in the fed and fasted state, detected through blood-oxygen-level dependent (BOLD) signal, in patients with severe obesity. approximately 6 weeks
Secondary BOLD signal change after lifestyle intervention The effect of 10% weight loss in patients with severe obesity induced by a lifestyle intervention on BOLD signal to taste in the fed and fasted state and compared to SG. average of 12 weeks
Secondary BOLD signal in response to taste in severe obesity compared to normal weight Brain responses, as BOLD signal, to taste in the fed and fasted state in severe obesity compared to normal weight baseline
Secondary BOLD signal change post-SG Whole brain neural response in BOLD signal to taste, in the fed and fasted state, 6 months following SG versus normal weight 6 months
Secondary Correlation of taste responses and gut hormones The relationship between the neural correlates of taste and levels of circulating gut hormones in severe obesity compared to normal weight baseline
Secondary Correlation of taste responses and gut hormones The relationship between the neural correlates of taste and levels of circulating gut hormones after 10% weight loss by SG compared to lifestyle intervention approximately 6 weeks for SG group and approximately 12 weeks for lifestyle intervention group
Secondary Correlation of taste responses and gut hormones The relationship between the neural correlates of taste and circulating gut hormone levels 6 months post-SG compared to baseline
Secondary Correlation of taste responses and gut hormones The relationship between the neural correlates of taste and levels of circulating gut hormones post-SG compared to normal weight 6 months
Secondary Brain structure Comparison of brain structure in severe obesity and normal weight Baseline
Secondary Brain structure 6 months following SG Comparison of brain structure 6 months following SG to baseline 6 months
Secondary Brain structure after 10% weight loss Comparison of brain structure following 10% weight loss induced by SG versus lifestyle intervention approximately 6 weeks for SG group and approximately 12 weeks for lifestyle intervention group
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2